Loading...
An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model
OBJECTIVE: Pulmonary fibrosis causes high morbidity and mortality in affected individuals. Recently, we showed that parenteral or intratracheal administration of a peptide derived from endostatin, called E4, prevents and ameliorates fibrosis using different models of dermal and pulmonary disease. No...
Saved in:
| Published in: | Int Immunopharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482421/ https://ncbi.nlm.nih.gov/pubmed/26315492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2015.07.039 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|